CVE-2020-12035

EPSS 0.2%CWE-287

Vexday Risk Score

3Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS —EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

29 Jun 2020Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The PrismaFlex device contains a hard-coded service password that provides access to biomedical information, device settings, calibration settings, and network configuration. This could allow an attacker to modify device settings and calibration.

Affected products

n/a · Baxter PrismaFlex and PrisMax

References

https://www.us-cert.gov/ics/advisories/icsma-20-170-01